Emma Walmsley earns £1M pay rise in her first full year at GSK’s helm — but £5.9M package still trails other Big Pharma CEOs

Emma Walmsley’s £1 million ($1.3 million) pay raise in 2018 might have made her the highest-paid women on the FTSE 100, but the GlaxoSmithKline CEO’s compensation package still trails her peers in Big Pharma corner offices.

In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)

← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 48,000+ biopharma executives who read Endpoints News every day.

Access is subject to the terms in our Privacy Policy.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 48,000+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Research Scientist - Immunology
Recursion Pharmaceuticals Salt Lake City, UT
Director of Operations
Atlas Venture Cambridge, MA

Visit Endpoints Careers ->